Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Gastrokine 1 protein is a potential theragnostic target for gastric cancer.

Yoon JH, Ham IH, Kim O, Ashktorab H, Smoot DT, Nam SW, Lee JY, Hur H, Park WS.

Gastric Cancer. 2018 Apr 27. doi: 10.1007/s10120-018-0828-8. [Epub ahead of print]

PMID:
29704153
2.

Screening and Identification of Peptides Specifically Targeted to Gastric Cancer Cells from a Phage Display Peptide Library

Sahin D, Taflan SO, Yartas G, Ashktorab H, Smoot DT.

Asian Pac J Cancer Prev. 2018 Apr 25;19(4):927-932.

3.

YAP/TAZ initiates gastric tumorigenesis via upregulation of MYC.

Choi W, Kim J, Park J, Lee DH, Hwang D, Kim JH, Ashktorab H, Smoot DT, Kim SY, Choi C, Koh GY, Lim DS.

Cancer Res. 2018 Apr 18. pii: canres.3487.2017. doi: 10.1158/0008-5472.CAN-17-3487. [Epub ahead of print]

PMID:
29669762
4.

Reduced lysosomal clearance of autophagosomes promotes survival and colonization of Helicobacter pylori.

Zhang L, Hu W, Cho CH, Chan FK, Yu J, Ross Fitzgerald J, Cheung CK, Xiao ZG, Shen J, Li LF, Li MX, Wu JC, Ling TK, Chan JY, Ko H, Tse G, Ng SC, Yu S, Wang MH, Gin T, Ashktorab H, Smoot DT, Wong SH, Chan MT, Wu WK.

J Pathol. 2018 Apr;244(4):432-444. doi: 10.1002/path.5033. Epub 2018 Feb 28.

PMID:
29327342
5.

Verteporfin inhibits gastric cancer cell growth by suppressing adhesion molecule FAT1.

Kang MH, Jeong GS, Smoot DT, Ashktorab H, Hwang CM, Kim BS, Kim HS, Park YY.

Oncotarget. 2017 Oct 19;8(58):98887-98897. doi: 10.18632/oncotarget.21946. eCollection 2017 Nov 17.

6.

Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.

Williams AD, Korolkova OY, Sakwe AM, Geiger TM, James SD, Muldoon RL, Herline AJ, Goodwin JS, Izban MG, Washington MK, Smoot DT, Ballard BR, Gazouli M, M'Koma AE.

PLoS One. 2017 Dec 6;12(12):e0189551. doi: 10.1371/journal.pone.0189551. eCollection 2017.

7.

PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer.

Mimura K, Teh JL, Okayama H, Shiraishi K, Kua LF, Koh V, Smoot DT, Ashktorab H, Oike T, Suzuki Y, Fazreen Z, Asuncion BR, Shabbir A, Yong WP, So J, Soong R, Kono K.

Cancer Sci. 2018 Jan;109(1):43-53. doi: 10.1111/cas.13424. Epub 2017 Nov 18.

8.

Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.

Williams AD, Korolkova OY, Sakwe AM, Geiger TM, James SD, Muldoon RL, Herline AJ, Goodwin JS, Izban MG, Washington MK, Smoot DT, Ballard BR, Gazouli M, M'Koma AE.

PLoS One. 2017 Aug 17;12(8):e0179710. doi: 10.1371/journal.pone.0179710. eCollection 2017. Erratum in: PLoS One. 2017 Dec 6;12 (12 ):e0189551.

9.

Heterodimeric interaction between GKN2 and TFF1 entails synergistic antiproliferative and pro-apoptotic effects on gastric cancer cells.

Kim O, Yoon JH, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

Gastric Cancer. 2017 Sep;20(5):772-783. doi: 10.1007/s10120-017-0692-y. Epub 2017 Feb 1.

PMID:
28150071
10.

Inhibition of histone/lysine acetyltransferase activity kills CoCl2-treated and hypoxia-exposed gastric cancer cells and reduces their invasiveness.

Rath S, Das L, Kokate SB, Ghosh N, Dixit P, Rout N, Singh SP, Chattopadhyay S, Ashktorab H, Smoot DT, Swamy MM, Kundu TK, Crowe SE, Bhattacharyya A.

Int J Biochem Cell Biol. 2017 Jan;82:28-40. doi: 10.1016/j.biocel.2016.11.014. Epub 2016 Nov 23.

11.

Race and colorectal cancer screening compliance among persons with a family history of cancer.

Laiyemo AO, Thompson N, Williams CD, Idowu KA, Bull-Henry K, Sherif ZA, Lee EL, Brim H, Ashktorab H, Platz EA, Smoot DT.

World J Gastrointest Endosc. 2015 Dec 10;7(18):1300-5. doi: 10.4253/wjge.v7.i18.1300.

12.

Gastrokine 1 inhibits gastrin-induced cell proliferation.

Kim O, Yoon JH, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

Gastric Cancer. 2016 Apr;19(2):381-91. doi: 10.1007/s10120-015-0483-2. Epub 2015 Mar 10.

13.

Gastrokine 1 inhibits the carcinogenic potentials of Helicobacter pylori CagA.

Yoon JH, Seo HS, Choi SS, Chae HS, Choi WS, Kim O, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

Carcinogenesis. 2014 Nov;35(11):2619-29. doi: 10.1093/carcin/bgu199. Epub 2014 Sep 19.

14.

Factors associated with attendance to scheduled outpatient endoscopy.

Laiyemo AO, Williams CD, Burnside C, Moghadam S, Sanasi-Bhola KD, Kwagyan J, Brim H, Ashktorab H, Scott VF, Smoot DT.

Postgrad Med J. 2014 Oct;90(1068):571-5. doi: 10.1136/postgradmedj-2012-131650. Epub 2014 Sep 1.

15.

nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer.

Lee KS, Park JL, Lee K, Richardson LE, Johnson BH, Lee HS, Lee JS, Kim SB, Kwon OH, Song KS, Kim YS, Ashktorab H, Smoot DT, Jeon SH, Kim SY, Lee YS.

Oncotarget. 2014 Jun 15;5(11):3944-55.

16.

The effect of Helicobacter pylori CagA on the HER-2 copy number and expression in gastric cancer.

Shim JH, Yoon JH, Choi SS, Ashktorab H, Smoot DT, Song KY, Nam SW, Lee JY, Park CH, Park WS.

Gene. 2014 Aug 10;546(2):288-96. doi: 10.1016/j.gene.2014.05.064. Epub 2014 May 28.

17.

Gastric Helicobacter pylori infection associates with an increased risk of colorectal polyps in African Americans.

Brim H, Zahaf M, Laiyemo AO, Nouraie M, Pérez-Pérez GI, Smoot DT, Lee E, Razjouyan H, Ashktorab H.

BMC Cancer. 2014 Apr 28;14:296. doi: 10.1186/1471-2407-14-296.

18.

MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer.

Shin JY, Kim YI, Cho SJ, Lee MK, Kook MC, Lee JH, Lee SS, Ashktorab H, Smoot DT, Ryu KW, Kim YW, Choi IJ.

PLoS One. 2014 Jan 21;9(1):e85205. doi: 10.1371/journal.pone.0085205. eCollection 2014.

19.

GKN2 contributes to the homeostasis of gastric mucosa by inhibiting GKN1 activity.

Kim O, Yoon JH, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

J Cell Physiol. 2014 Jun;229(6):762-71. doi: 10.1002/jcp.24496.

PMID:
24151046
20.

Adenocarcinomas After Prophylactic Surgery For Familial Adenomatous Polyposis.

Smith JC, Schäffer MW, Ballard BR, Smoot DT, Herline AJ, Adunyah SE, M'Koma AE.

J Cancer Ther. 2013;4(1):260-270.

21.

GKN1-miR-185-DNMT1 axis suppresses gastric carcinogenesis through regulation of epigenetic alteration and cell cycle.

Yoon JH, Choi YJ, Choi WS, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

Clin Cancer Res. 2013 Sep 1;19(17):4599-610. doi: 10.1158/1078-0432.CCR-12-3675. Epub 2013 Jul 11.

22.

Gastrokine 1 regulates NF-κB signaling pathway and cytokine expression in gastric cancers.

Yoon JH, Cho ML, Choi YJ, Back JY, Park MK, Lee SW, Choi BJ, Ashktorab H, Smoot DT, Nam SW, Lee JY, Park WS.

J Cell Biochem. 2013 Aug;114(8):1800-9. doi: 10.1002/jcb.24524.

23.

Short- and long-term risk of colorectal adenoma recurrence among whites and blacks.

Laiyemo AO, Doubeni C, Brim H, Ashktorab H, Schoen RE, Gupta S, Charabaty A, Lanza E, Smoot DT, Platz E, Cross AJ.

Gastrointest Endosc. 2013 Mar;77(3):447-54. doi: 10.1016/j.gie.2012.11.027. Epub 2013 Jan 18.

24.

SILAC-based quantitative proteomic analysis of gastric cancer secretome.

Marimuthu A, Subbannayya Y, Sahasrabuddhe NA, Balakrishnan L, Syed N, Sekhar NR, Katte TV, Pinto SM, Srikanth SM, Kumar P, Pawar H, Kashyap MK, Maharudraiah J, Ashktorab H, Smoot DT, Ramaswamy G, Kumar RV, Cheng Y, Meltzer SJ, Roa JC, Chaerkady R, Prasad TS, Harsha HC, Chatterjee A, Pandey A.

Proteomics Clin Appl. 2013 Jun;7(5-6):355-66. doi: 10.1002/prca.201200069. Epub 2013 May 21.

25.

Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker: implications in molecular imaging.

Yang Y, Toy W, Choong LY, Hou P, Ashktorab H, Smoot DT, Yeoh KG, Lim YP.

J Proteome Res. 2012 Dec 7;11(12):5736-47. doi: 10.1021/pr300555y. Epub 2012 Nov 26.

26.

Helicobacter pylori protection against reflux esophagitis.

Ashktorab H, Entezari O, Nouraie M, Dowlati E, Frederick W, Woods A, Lee E, Brim H, Smoot DT, Ghadyari F, Kamangar F, Razjouyan H.

Dig Dis Sci. 2012 Nov;57(11):2924-8. doi: 10.1007/s10620-012-2349-3. Epub 2012 Sep 26.

27.

Isorhamnetin inhibits proliferation and invasion and induces apoptosis through the modulation of peroxisome proliferator-activated receptor γ activation pathway in gastric cancer.

Ramachandran L, Manu KA, Shanmugam MK, Li F, Siveen KS, Vali S, Kapoor S, Abbasi T, Surana R, Smoot DT, Ashktorab H, Tan P, Ahn KS, Yap CW, Kumar AP, Sethi G.

J Biol Chem. 2012 Nov 2;287(45):38028-40. doi: 10.1074/jbc.M112.388702. Epub 2012 Sep 19. Erratum in: J Biol Chem. 2013 Jun 28;288(26):18777.

28.

Obesity, weight change, and risk of adenoma recurrence: a prospective trial.

Laiyemo AO, Doubeni C, Badurdeen DS, Murphy G, Marcus PM, Schoen RE, Lanza E, Smoot DT, Cross AJ.

Endoscopy. 2012 Sep;44(9):813-8. doi: 10.1055/s-0032-1309837. Epub 2012 Aug 27.

29.

Timing of procedure and compliance with outpatient endoscopy among an underserved population in an inner-city tertiary institution.

Badurdeen DS, Umar NA, Begum R, Sanderson AK 2nd, Jack M, Mekasha G, Kwagyan J, Smoot DT, Laiyemo AO.

Ann Epidemiol. 2012 Jul;22(7):531-5. doi: 10.1016/j.annepidem.2012.04.013. Epub 2012 May 8.

30.

LARP7 is a potential tumor suppressor gene in gastric cancer.

Cheng Y, Jin Z, Agarwal R, Ma K, Yang J, Ibrahim S, Olaru AV, David S, Ashktorab H, Smoot DT, Duncan MD, Hutcheon DF, Abraham JM, Meltzer SJ, Mori Y.

Lab Invest. 2012 Jul;92(7):1013-9. doi: 10.1038/labinvest.2012.59. Epub 2012 Apr 9.

31.

Contribution of higher risk genes and European admixture to Crohn's disease in African Americans.

Wang MH, Okazaki T, Kugathasan S, Cho JH, Isaacs KL, Lewis JD, Smoot DT, Valentine JF, Kader HA, Ford JG, Harris ML, Oliva-Hemker M, Cuffari C, Torbenson MS, Duerr RH, Silverberg MS, Rioux JD, Taylor KD, Nguyen GC, Wu Y, Datta LW, Hooker S, Dassopoulos T, Kittles RA, Kao LW, Brant SR.

Inflamm Bowel Dis. 2012 Dec;18(12):2277-87. doi: 10.1002/ibd.22931. Epub 2012 Mar 12.

32.

Scheduled out-patient endoscopy and lack of compliance in a minority serving tertiary institution.

Jackson DS, Egbuonnu N, Umunakwe C, Fullum TM, Ford DH, Anders KB, McDonald-Pinkett S, Smoot DT, Laiyemo AO.

Am J Med Sci. 2012 Sep;344(3):194-8. doi: 10.1097/MAJ.0b013e31823ea5b0.

33.

Case-control study of vitamin D, dickkopf homolog 1 (DKK1) gene methylation, VDR gene polymorphism and the risk of colon adenoma in African Americans.

Ashktorab H, Nguza B, Fatemi M, Nouraie M, Smoot DT, Schäffer AA, Kupfer SS, Camargo CA Jr, Brim H.

PLoS One. 2011;6(10):e25314. doi: 10.1371/journal.pone.0025314. Epub 2011 Oct 13.

34.

Esophageal carcinoma in African Americans: a five-decade experience.

Ashktorab H, Nouri Z, Nouraie M, Razjouyan H, Lee EE, Dowlati E, El-Seyed el-W, Laiyemo A, Brim H, Smoot DT.

Dig Dis Sci. 2011 Dec;56(12):3577-82. doi: 10.1007/s10620-011-1853-1. Epub 2011 Aug 17.

35.

CD44-SLC1A2 gene fusions in gastric cancer.

Tao J, Deng NT, Ramnarayanan K, Huang B, Oh HK, Leong SH, Lim SS, Tan IB, Ooi CH, Wu J, Lee M, Zhang S, Rha SY, Chung HC, Smoot DT, Ashktorab H, Kon OL, Cacheux V, Yap C, Palanisamy N, Tan P.

Sci Transl Med. 2011 Apr 6;3(77):77ra30. doi: 10.1126/scitranslmed.3001423.

36.

Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo.

Hao Y, Gu X, Zhao Y, Greene S, Sha W, Smoot DT, Califano J, Wu TC, Pang X.

Cancer Prev Res (Phila). 2011 Jul;4(7):1073-83. doi: 10.1158/1940-6207.CAPR-10-0333. Epub 2011 Mar 23.

37.

Upregulation of plasma C9 protein in gastric cancer patients.

Chong PK, Lee H, Loh MC, Choong LY, Lin Q, So JB, Lim KH, Soo RA, Yong WP, Chan SP, Smoot DT, Ashktorab H, Yeoh KG, Lim YP.

Proteomics. 2010 Sep;10(18):3210-21. doi: 10.1002/pmic.201000127.

38.

ITIH3 is a potential biomarker for early detection of gastric cancer.

Chong PK, Lee H, Zhou J, Liu SC, Loh MC, Wang TT, Chan SP, Smoot DT, Ashktorab H, So JB, Lim KH, Yeoh KG, Lim YP.

J Proteome Res. 2010 Jul 2;9(7):3671-9. doi: 10.1021/pr100192h.

39.

Clinicopathological features of colon polyps from African-Americans.

Nouraie M, Hosseinkhah F, Brim H, Zamanifekri B, Smoot DT, Ashktorab H.

Dig Dis Sci. 2010 May;55(5):1442-9. doi: 10.1007/s10620-010-1133-5. Epub 2010 Mar 12.

40.

Distinct genetic alterations in colorectal cancer.

Ashktorab H, Schäffer AA, Daremipouran M, Smoot DT, Lee E, Brim H.

PLoS One. 2010 Jan 26;5(1):e8879. doi: 10.1371/journal.pone.0008879.

41.

NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans.

Dassopoulos T, Nguyen GC, Talor MV, Datta LW, Isaacs KL, Lewis JD, Gold MS, Valentine JF, Smoot DT, Harris ML, Oliva-Hemker M, Bayless TM; NIDDK IBD Genetics Consortium, Burek CL, Brant SR.

Am J Gastroenterol. 2010 Feb;105(2):378-86. doi: 10.1038/ajg.2009.575. Epub 2009 Oct 13.

42.

Outcome of colonoscopy in elderly African-American patients.

Smoot DT, Collins J, Dunlap S, Ali-Ibrahim A, Nouraie M, Lee EL, Ashktorab H.

Dig Dis Sci. 2009 Nov;54(11):2484-7. doi: 10.1007/s10620-009-0965-3.

PMID:
19757049
43.

Distinct high-profile methylated genes in colorectal cancer.

Mokarram P, Kumar K, Brim H, Naghibalhossaini F, Saberi-firoozi M, Nouraie M, Green R, Lee E, Smoot DT, Ashktorab H.

PLoS One. 2009 Sep 11;4(9):e7012. doi: 10.1371/journal.pone.0007012.

44.

Upper gastrointestinal bleeding from metastatic testicular cancer.

Laiyemo AO, Jack M, Dawkins FW, Smoot DT.

J Natl Med Assoc. 2009 Aug;101(8):808-9.

PMID:
19715045
45.

Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans.

Kumar K, Brim H, Giardiello F, Smoot DT, Nouraie M, Lee EL, Ashktorab H.

Clin Cancer Res. 2009 Feb 15;15(4):1155-61. doi: 10.1158/1078-0432.CCR-08-1029. Epub 2009 Feb 3.

46.

H. pylori-induced apoptosis in human gastric cancer cells mediated via the release of apoptosis-inducing factor from mitochondria.

Ashktorab H, Dashwood RH, Dashwood MM, Zaidi SI, Hewitt SM, Green WR, Lee EL, Daremipouran M, Nouraie M, Malekzadeh R, Smoot DT.

Helicobacter. 2008 Dec;13(6):506-17. doi: 10.1111/j.1523-5378.2008.00646.x.

PMID:
19166416
47.

Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study.

Brim H, Mokarram P, Naghibalhossaini F, Saberi-Firoozi M, Al-Mandhari M, Al-Mawaly K, Al-Mjeni R, Al-Sayegh A, Raeburn S, Lee E, Giardiello F, Smoot DT, Vilkin A, Boland CR, Goel A, Hafezi M, Nouraie M, Ashktorab H.

Mol Cancer. 2008 Aug 21;7:68. doi: 10.1186/1476-4598-7-68.

48.

Metastatic gastric stump cancer occurring six years after a partial gastrectomy for gastric ulcer.

Laiyemo AO, Smoot DT.

J Natl Med Assoc. 2008 Jun;100(6):737-9.

PMID:
18595579
49.

Sporadic colon cancer: mismatch repair immunohistochemistry and microsatellite instability in Omani subjects.

Ashktorab H, Brim H, Al-Riyami M, Date A, Al-Mawaly K, Kashoub M, Al-Mjeni R, Smoot DT, Al-Moundhri M, Al-Hashemi S, Ganguly SS, Raeburn S.

Dig Dis Sci. 2008 Oct;53(10):2723-31. doi: 10.1007/s10620-007-0189-3. Epub 2008 Feb 26.

PMID:
18299982
50.

Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer.

Ashktorab H, Daremipouran M, Wilson M, Siddiqi S, Lee EL, Rakhshani N, Malekzadeh R, Johnson AC, Hewitt SM, Smoot DT.

Am J Gastroenterol. 2007 Oct;102(10):2135-46. Epub 2007 Jul 7.

PMID:
17617207

Supplemental Content

Loading ...
Support Center